ASGCT 2025: Gene Therapy Post-Conference Report
Our Post-Conference Report offers an in-depth analysis and summary of the 181 gene therapy-related abstracts presented at the 2025 ASGCT Annual Meeting. This report is an essential resource for staying updated on the latest developments and innovations in the field.
Highlights include:
- Analysis of the abstracts by the delivery system being investigated, top 10 diseases, and trial phase.
- A comprehensive summary of each abstract, including trial sponsor, delivery system, trial results, and safety outcomes.
- Convenient links to corresponding drug and trial pages on Beacon ensure easy access to further information.
We hope you find this report useful and insightful. We are as excited as you are to see the latest developments in gene therapy.
You May Also Be Interested In…
Learn More About Gene Therapy
- The Most Comprehensive Way to Search the Gene Therapy Development Landscape: Unique search ontologies based on Gene Therapy drug and trial characteristics
- Market Leading Approach to Gene Therapy Preclinical & Clinical Data Curation: Manual curation of key Gene Therapy research and development data points by Gene Therapy research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Gene Therapy company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
